Pulmatrix, Inc. (“Pulmatrix,” the “Company,” “we,” “our” or “us”) (NASDAQ: PULM) today announced the closing and funding of its previously announced underwritten public offering of 5,323,530 shares of its common stock at a price to the public of $0.17 per share
February 5, 2019
· 4 min read